Pathological gambling and hypersexuality in cabergoline-treated prolactinoma

Falhammar, Henrik; Yarker, Jennifer Y

doi:10.5694/j.1326-5377.2009.tb02289.x

Topics

To the Editor: A 50-year-old man presented with gynaecomastia and galactorrhoea, reporting diminished libido and energy over 12 months. Previous medical and psychiatric histories were unremarkable.

Department of Endocrinology, Cairns Base Hospital, Cairns, QLD.

Correspondence: henrik.falhammar@ki.se

1. Gallagher DA, O’Sullivan SS, Evans AH, et al. Pathological gambling in Parkinson’s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007; 22: 1757-1763.
2. Avanzi M, Baratti M, Cabrini S, et al. Prevalence of pathological gambling in patients with Parkinson’s disease. Mov Disord 2006; 21: 2068-2072.
3. Davie M. Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma. J Neuropsychiatry Clin Neurosci 2007; 19: 473-474.
4. Nyholm D. Pharmacokinetic optimisation in the treatment of Parkinson’s disease: an update. Clin Pharmacokinet 2006; 45: 109-136.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.

Online responses are no longer available. Please refer to our instructions for authors page for more information.